奇德新材(300995.SZ):生產設備、工藝、技術適用於PEEK材料的改性應用和注塑成型應用
格隆匯5月19日丨奇德新材(300995.SZ)在投資者互動平臺表示,在高分子複合材料方面,公司掌握了玻璃纖維增強、碳纖維增強、高緻密度玻璃纖維表面處理及分散等核心技術,公司聚焦工程塑料及特種工程塑料的高性能化及低成本化研究。公司的生產設備、工藝、技術適用於PEEK材料的改性應用和注塑成型應用,對PEEK的高性能化、高耐磨、耐疲勞方面具有生產和技術基礎。未來,公司將加大對下遊客戶PEEK的需求研究,同時積極對下遊應用場景進行材料驗證,持續推動以塑代鋼,國產化替代的工業發展趨勢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.